A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer

Gynecologic Oncology

Volumn 96, Issue 1, 2005, Pages 198-203

  Duska, Linda R ^a   Berkowitz, Ross ^b   Matulonis, Ursula ^c   Muto, Michael ^b   Goodman, Annekathryn ^a   Mcintyre, James F ^d   Klein, Amber ^a   Atkinson, Tina ^c   Seiden, Michael V ^a   Campos, Susana ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d Boston MA 02114 USA   (United States)

Author keywords

Chemotherapy; Endometrial cancer; Radiotherapy

Indexed keywords

CARBOPLATIN; DOXORUBICIN; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CARDIOTOXICITY; CHROMAFFIN SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DEHYDRATION; DIARRHEA; DRUG EFFECT; DRUG TOLERABILITY; ENDOMETRIUM CARCINOMA; EVALUATION; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL TOXICITY; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HUMAN CELL; HYPERSENSITIVITY; INFECTION; INTESTINE OBSTRUCTION; LAPAROTOMY; LEUKOPENIA; LONG TERM CARE; METABOLIC DISORDER; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; OUTPATIENT; PAIN; PRIORITY JOURNAL; RADIATION INJURY; RISK ASSESSMENT; SEPSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARBOPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ENDOMETRIAL NEOPLASMS; FEMALE; FILGRASTIM; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PILOT PROJECTS; RISK FACTORS;

EID: 10044283040     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.09.022     Document Type: Article

References (11)

1. Randall M, Brunetto G, Muss H, et al. Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: a randomized phase III trial of the Gynecologic Oncology Group. ASCO 2003, Abstract #3.
2. J.T. Thigpen, J.A. Blessing, L.D. Lagasse, P.J. DiSaia, and H.D. Homesley Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group study Am. J. Clin. Oncol. 7 1984 253 256
3. J.T. Thigpen, H.J. Buchsbaum, C. Mangan, and J.A. Blessing Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study Cancer Treat. Rep. 63 1979 21 27
4. J. Thigpen, J. Blessing, H. Homesley, J. Malfetano, P. DiSaia, and E. Yordan Phase III trial of doxorubicin ± cisplating in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group (GOG) study Proc. Am. Soc. Clin. Oncol. 12 1993 261
5. H.H. Gallion, V.L. Brunetto, and M. Cibull Randomized phase III trial of standard timed doxorubicin plus cisplatin versus circadian timed doxorubicin plus cisplatin in stage III and IV or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study J. Clin. Oncol. 21 2003 3808 3813
6. H.G. Ball, J.A. Blessing, S.S. Lentz, and D.G. Mutch A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study Gynecol. Oncol. 62 1996 278 281
7. G.F. Fleming, V.L. Brunetto, D. Cella, K.Y. Look, G.C. Reid, and A.R. Munkarah Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study J. Clin. Oncol. 22 2004 2159 2166
8. T.W. Burke, A. Munkarah, and J.J. Kavanagh Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin Gynecol. Oncol. 51 1993 397 400
9. S.A. Reisinger, R. Asbury, S.Y. Liao, and H.D. Homesley A phase I study of weekly cisplatin and whole abdominal radiation for the treatment of stage III and IV endometrial carcinoma: a Gynecologic Oncology Group pilot study Gynecol. Oncol. 63 1996 299 303
10. T. Onda, H. Yoshikawa, and K. Mizutani Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy Br. J. Cancer 75 1997 1836 1841
11. G.F. Fleming, J.M. Fowler, and S.E. Waggoner Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study J. Clin. Oncol. 19 2001 1021 1029